Affordable Access

Access to the full text

Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients

Authors
  • Rouve, Emmanuelle1
  • Lakhal, Karim2
  • Salmon Gandonnière, Charlotte1, 3
  • Jouan, Youenn1, 3
  • Bodet-Contentin, Laetitia1, 3
  • Ehrmann, Stephan1, 3
  • 1 CHRU de Tours, Medecine Intensive Reanimation, CIC 1415, CRICS-Triggersep network, Tours, France , Tours (France)
  • 2 Hôpital Laënnec, centre hospitalier universitaire, Reanimation chirurgicale polyvalente, service d’anesthesie-reanimation, Nantes, France , Nantes (France)
  • 3 Université de Tours, Faculté de médecine, Tours, France , Tours (France)
Type
Published Article
Journal
BMC Nephrology
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 06, 2018
Volume
19
Issue
1
Identifiers
DOI: 10.1186/s12882-018-1091-2
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundIodinated contrast media may contribute to acute kidney injury. However, several recent works suggest that this toxicity is minimal in the clinical setting. Recently, urinary G1 cell-cycle arrest proteins tissue inhibitor of metalloproteinase 2 (TIMP-2) and insulin like growth factor binding protein 7 (IGFBP-7) were identified as highly sensitive and specific biomarkers for early detection of kidney aggression. The impact of contrast administration on those biomarkers has not been specifically evaluated but could provide clues about the toxicity of contrast media. This study aimed at measuring changes in TIMP-2 and IGFBP-7 urinary concentrations before and after a contrast-enhanced computed tomography in critically ill patients.Methods77 patients were included in a prospective observational cohort study. Urinary [TIMP -2]·[IGFBP-7] was measured before, 6 and 24 h after contrast infusion. Urine output and serum creatinine were followed 3 days.ResultsMedian [TIMP-2]·[IGFBP-7] was 0.06 [interquartile range 0.04;0.26], 0.07 [0.03;0.34] and 0.10 [0.04;0.37] (ng/mL)2/1000 respectively before, 6 and 24 h after contrast infusion. Individual changes from baseline were − 0.01 [− 0.11;0.11] and 0.00 [− 0.10;0.09] (ng/ml)2/1000 at 6 and 24 h. These changes were not higher among the patients increasing their Kidney Disease Improving Global Outcome (KDIGO) classification within 3 days after contrast infusion (n = 14 [18%] based on creatinine criterion only, n = 42 [55%] based on creatinine and urine output).ConclusionsChanges in [TIMP-2]·[IGFBP-7] urinary concentration after contrast-enhanced computed tomography were insignificant, suggesting minimal kidney aggression by modern iodinated contrast media.

Report this publication

Statistics

Seen <100 times